China’s leading financial officials released a rare statement warning about the potential rise of commodity prices and consumer inflation, which has become a global concern as major central banks have …
Featured Posts Title
Swans rest in Qingshui River at Miyun Reservoir basin in Beijing
China moving forward to occupy Taiwan, warn US agencies, citing Beijing’s increasing military preparation and modernisation
China takes spat with Japan over Taiwan to UN, vows to defend itself
Japan Blasts China’s UN Letter Claim as Baseless, Urges Dialogue
Ex-general says Saudis unlikely to leak F-35 tech, but China ‘could exploit through intel’
How to watch Corona Centennial vs. Mater Dei (11/21/25) | Stream CIF-SS Football Playoffs online with NFHS Network
China enjoys marriage boom as Beijing allows weddings in nightclubs
Recent Posts
China issues inflation warning as rising commodity, consumer prices threaten economic recovery
How the digital yuan stablecoin impacts crypto in China: Experts answer
Here’s what crypto and blockchain industry experts from China think about the digital yuan and how it has affected the blockchain space. In 2017, the PBoC launched the Digital Currency Research …
China has a privacy problem. New data laws could help curb the worst abuses – but not all of them
When PIPL goes into effect, sometime later this year or next, it may help curb some of China’s most widespread privacy abuses – but don’t hold out hope it will address the significant imbalance where…
China tries to wear down its neighbors with pressure tactics
WASHINGTON — China is trying to wear down its neighbors with relentless pressure tactics designed to push its territorial claims, employing military aircraft, militia boats and sand dredgers to …
China’s COVID-19 vaccine output to hit 3 billion by year-end – official
CHENGDU, China (Reuters) – China’s will likely have produced 3 billion doses of COVID-19 vaccines by the end of the year, a National Health Commission official said on Saturday. Zheng Zhongwei, who …
China’s COVID-19 vaccine output could exceed 3 billion by year-end – official
China’s output of COVID-19 vaccines could reach more than 3 billion doses by the end of 2021, a National Health Commission official said on Saturday. Zheng Zhongwei, who also heads a team coordinating …
Events Leading up to China’s $2.75 Billion Fine on Alibaba
Events Leading up to China’s $2.75 Billion Fine on Alibaba The Alibaba business empire has come under intense scrutiny in China since its billionaire founder Jack Ma’s stinging public criticism of the …
Alibaba Group Has Received the Administrative Penalty Decision Issued by the State Administration for Market Regulation of the People’s Republic of China
800 820 2079 China Mobile: 400 820 6895 Conference ID: 6934098 (English) A live webcast of the conference call can be accessed at https://edge.media-server.com/mmc/p/t76yro7p. An archived webcast will …
ZTE Secures China Mobile’s New SPN Centralized Procurement
ZTE Corporation has announced that it has secured the largest share in China’s 11 provinces in China Mobile’s bidding of new SPN project centralized procurement 2021-2022, and been selected in all 26 …
China’s Sinopharm, Sinovac COVID-19 vaccines in final stages of evaluation: WHO
China’s Sinopharm, Sinovac COVID-19 vaccines are in the final stages of evaluation, said the World Health Organization (WHO). The two Chinese vaccines, once approved, will be used under the WHO’s …
China Fines Alibaba Record $2.8 Billion After Monopoly Probe
China imposed a record fine of 18.2 billion yuan ($2.8 billion) on Alibaba Group Holding Ltd. after an anti-monopoly probe found that it had abused its dominant market position.The penalty is triple …
China’s Didi prepares for IPO in US, sources say
BEIJING — Didi Chuxing, China’s top ride-hailing company, is preparing an IPO in the U.S., Nikkei has learned. The IPO is expected to value the company at around $70 billion to $100 billion.
Sinopharm’s protein-based COVID-19 vaccine candidate gets China clinical trial nod
BEIJING, April 10 (Reuters) – The China National Biotec Group Company (CNBG) has obtained regulatory approval to move a third COVID-19 vaccine candidate into the human testing stage in China, CNBG …
